The Washington Post
Millions of middle-aged American men who get tested regularly for
prostate cancer but show no signs of the illness might benefit from
taking a drug that substantially lowers their risk of getting the
disease, according to new guidelines issued by two leading medical
groups that treat prostate cancer... Read More